1Peter L. Devine,Maree A. Duroux,Rachel J. Quin,Michael A. McGuckin,Gloria J. Joy,Bruce G. Ward,Clifford W. Pollard. CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer[J] 1995,Breast Cancer Research and Treatment(3):245～251
6Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia [ J ] . Cancer, 1993, 71(4): 1258-1265.
7Dupont WD,Parl FF,Hartmann WH,et al.Breast cancer risk associated with proliferative breast disease and atypical hyperplasia[J].Cancer,1993,71(4):1258-1265.
8Clurman Be,Roberts JM. Cell cycle and cancer[J]. J Natl Cancer Inst, 1995,87(20) : 1499-1501.
9Massidda B, Ionta MT, Foddi MR. Usefulness of pyridinium crosslinks and CA153 as markers in metastatic bone brest carcionoma[Jl. Anticancer Res, 1996, 16 (4) : 2221-2223.
10Grana X, Reddy EP. Cycle control in mammalian cells:role of cyclins, cyclin dependent kinases (CDKS), growth supressor genes and cyclin-dependent kinase inhibitors (CKIS)[J]. Oncogene, 1995,11 (2) :211-219.
